Your browser doesn't support javascript.
loading
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.
Han, Xuexiang; Alameh, Mohamad-Gabriel; Butowska, Kamila; Knox, James J; Lundgreen, Kendall; Ghattas, Majed; Gong, Ningqiang; Xue, Lulu; Xu, Ying; Lavertu, Marc; Bates, Paul; Xu, Junchao; Nie, Guangjun; Zhong, Yi; Weissman, Drew; Mitchell, Michael J.
Afiliação
  • Han X; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
  • Alameh MG; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Butowska K; Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Knox JJ; Department of Bioengineering, George Mason University, Fairfax, VA, USA.
  • Lundgreen K; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
  • Ghattas M; Intercollegiate Faculty of Biotechnology, University of Gdansk & Medical University of Gdansk, Gdansk, Poland.
  • Gong N; Department of Pathology, University of Pennsylvania, Philadelphia, PA, USA.
  • Xue L; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.
  • Xu Y; Department of Chemical Engineering, Polytechnique Montreal, Montreal, Quebec, Canada.
  • Lavertu M; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
  • Bates P; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
  • Xu J; Department of Chemistry, Case Western Reserve University, Cleveland, OH, USA.
  • Nie G; Department of Chemical Engineering, Polytechnique Montreal, Montreal, Quebec, Canada.
  • Zhong Y; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.
  • Weissman D; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, People's Republic of China.
  • Mitchell MJ; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, People's Republic of China.
Nat Nanotechnol ; 18(9): 1105-1114, 2023 09.
Article em En | MEDLINE | ID: mdl-37365276
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article